Literature DB >> 29494361

Using Unsupervised Machine Learning to Identify Subgroups Among Home Health Patients With Heart Failure Using Telehealth.

Eliezer Bose1, Kavita Radhakrishnan.   

Abstract

This study explored the use of unsupervised machine learning to identify subgroups of patients with heart failure who used telehealth services in the home health setting, and examined intercluster differences for patient characteristics related to medical history, symptoms, medications, psychosocial assessments, and healthcare utilization. Using a feature selection algorithm, we selected seven variables from 557 patients for clustering. We tested three clustering techniques: hierarchical, k-means, and partitioning around medoids. Hierarchical clustering was identified as the best technique using internal validation methods. Intercluster differences among patient characteristics and outcomes were assessed with either χ test or one-way analysis of variance. Ranging in size from 153 to 233 patients, three clusters displayed patterns that differed significantly (P < .05) in patient characteristics of age, sex, medical history of comorbid conditions, use of beta blockers, and quality of life assessment. Significant (P < .001) intercluster differences in number of medications, comorbidities, and healthcare utilization were also revealed. The study identified patterns of association between (1) mental health status, pulmonary disorders, and obesity, and (2) healthcare utilization for patients with heart failure who used telehealth in the home health setting. Study results also revealed a lack of prescription guideline-recommended heart failure medications for the subgroup with the highest proportion of older female adults.

Entities:  

Mesh:

Year:  2018        PMID: 29494361     DOI: 10.1097/CIN.0000000000000423

Source DB:  PubMed          Journal:  Comput Inform Nurs        ISSN: 1538-2931            Impact factor:   1.985


  7 in total

1.  Changing landscape of nursing homes serving residents with dementia and mental illnesses.

Authors:  Huiwen Xu; Orna Intrator; Eva Culakova; John R Bowblis
Journal:  Health Serv Res       Date:  2021-11-17       Impact factor: 3.734

2.  Simulation-derived best practices for clustering clinical data.

Authors:  Caitlin E Coombes; Xin Liu; Zachary B Abrams; Kevin R Coombes; Guy Brock
Journal:  J Biomed Inform       Date:  2021-04-20       Impact factor: 8.000

3.  Identifying knowledge gaps in heart failure research among women using unsupervised machine-learning methods.

Authors:  Khalid Alhussain; Kazuhiko Kido; Nilanjana Dwibedi; Traci LeMasters; Danielle E Rose; Ranjita Misra; Usha Sambamoorthi
Journal:  Future Cardiol       Date:  2021-01-11

4.  Improving Detection of Disease Re-emergence Using a Web-Based Tool (RED Alert): Design and Case Analysis Study.

Authors:  Nidhi Parikh; Ashlynn R Daughton; William Earl Rosenberger; Derek Jacob Aberle; Maneesha Elizabeth Chitanvis; Forest Michael Altherr; Nileena Velappan; Geoffrey Fairchild; Alina Deshpande
Journal:  JMIR Public Health Surveill       Date:  2021-01-07

5.  Machine learning for subtype definition and risk prediction in heart failure, acute coronary syndromes and atrial fibrillation: systematic review of validity and clinical utility.

Authors:  Amitava Banerjee; Suliang Chen; Ghazaleh Fatemifar; Mohamad Zeina; R Thomas Lumbers; Johanna Mielke; Simrat Gill; Dipak Kotecha; Daniel F Freitag; Spiros Denaxas; Harry Hemingway
Journal:  BMC Med       Date:  2021-04-06       Impact factor: 11.150

6.  Comparison of Unsupervised Machine Learning Approaches for Cluster Analysis to Define Subgroups of Heart Failure with Preserved Ejection Fraction with Different Outcomes.

Authors:  Hirmand Nouraei; Hooman Nouraei; Simon W Rabkin
Journal:  Bioengineering (Basel)       Date:  2022-04-16

7.  Identifying novel subgroups in heart failure patients with unsupervised machine learning: A scoping review.

Authors:  Jin Sun; Hua Guo; Wenjun Wang; Xiao Wang; Junyu Ding; Kunlun He; Xizhou Guan
Journal:  Front Cardiovasc Med       Date:  2022-07-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.